This website is intended for US healthcare professionals
Are you a healthcare professional in the US?
Yes
No

Proud to partner with the Veterans Administration

The Department of Veterans Affairs reports that veterans are more likely to experience migraine than civilians. 1

The Global Burden of Disease (GBD) study of 2016 ranks migraine, in years of life lived with disability, as the second most disabling disorder globally. 2

Nerivio VA Ordering Information
Prescribe Nerivio using this form . Available also via e-prescription*
1
Send the prescription to ProCare Rx
2
ProCare Rx will deliver Nerivio directly to your patient
3
Nerivio really helped me!
Nerivio

For Teens

FDA
Approved
Treat &
Prevent
Ages
8 & Up

To order Nerivio, please follow these steps:

1. Medical Provider submits order to Prosthetics/Pharmacy
Product
Description
# of devices
A. Item #: Nerivio 3
Three Months of Treatment
3
B. Item #: Nerivio 6
Six Months of Treatment
6
C. Item #: Nerivio 12
Twelve Months of Treatment
12
FSS #: 36F79721D0103
2. Prosthetics sends the PO for Nerivio

ORDERING CONTACT:

Veterans Medical Distributors, Inc.

Email: office@vmdinc.com

Phone: (561)588-3222

High five for freedom from medication complications and side effects

Drug-free and non-addictive
No systemic side effects
No pills, no needles
No risk of overuse
Use alone or alongside medication 

Drug-free, easy-to-use, non-invasive wearable device to treat and prevent migraine

EFFECTIVE

66.7% of patients  found relief from their migraine pain at 2 hrs post treatment. (3)
4 migraine days reduction when used every other day. (5)

SAFE

96.4% of patients studied did not report any device related side effects. (3)
‍ 0 device-related adverse events reported in pivotal prevention trial. (5)

EASY-TO-USE

89.7% of patients opted to treat with REN (Nerivio) to avoid medication use. (4)

Sources

  1. americanmigrainefoundation.org
  2. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17(11):954-976. doi:10.1016/S1474-4422(18)30322-3
  3. Yarnitsky D, Dodick DW, Grosberg BM, Burstein R, Ironi A, Harris D, Lin T, Silberstein SD. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial. Headache. 2019;59(8): 1240-1252
  4. Marmura MJ, Lin T, Harris D, lroni A, Rosen NL. Incorporating Remote Electrical Neuromodulation (REN) Into Usual Care Reduces Acute Migraine Medication. Use: An Open-Label Extension Study. Frontiers in Neurology. 2020; 11 :226
  5. Tepper SJ, et al. Remote electrical neuromodulation for migraine prevention: A double-blind, randomized, placebo-controlled clinical trial. Headache. 2023. doi: 10.1111/head.14469.

‍